The Glucagon-Like Peptide 1 Analogue Exendin-4 Attenuates the Nicotine-Induced Locomotor Stimulation, Accumbal Dopamine Release, Conditioned Place Preference as well as the Expression of Locomotor Sensitization in Mice

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Egecioglu, Emil ^a   Engel, Jörgen A ^a   Jerlhag, Elisabet ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; EXENDIN 4; GLUCAGON LIKE PEPTIDE 1; LIRAGLUTIDE; NICOTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DOPAMINE RELEASE; FOOD INTAKE; GLUCAGON RELEASE; GLUCOSE HOMEOSTASIS; INSULIN RELEASE; LOCOMOTION; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PLACE PREFERENCE; SENSITIZATION; SMOKING CESSATION; STOMACH EMPTYING; TOBACCO DEPENDENCE;

ANIMALS; CONDITIONING (PSYCHOLOGY); DOPAMINE; EATING; GLUCAGON-LIKE PEPTIDE 1; INCRETINS; LIMBIC SYSTEM; MALE; MICE; MOTOR ACTIVITY; NICOTINE; NUCLEUS ACCUMBENS; PEPTIDES; RECEPTORS, GLUCAGON; REWARD; TOBACCO USE DISORDER; VENOMS;

EID: 84885696767     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077284     Document Type: Article

References (51)

1. Duaso M, Duncan D, (2012) Health impact of smoking and smoking cessation strategies: current evidence. Br J Community Nurs 17: 356-363. PubMed: 22875209.
2. Larsson A, Engel JA, (2004) Neurochemical and behavioral studies on ethanol and nicotine interactions. Neurosci Biobehav Rev 27: 713-720. doi:10.1016/j.neubiorev.2003.11.010. PubMed: 15019421.
3. Volkow ND, Li TK, (2004) Drug addiction: the neurobiology of behaviour gone awry. Nat Rev Neurosci 5: 963-970. doi:10.1038/nrn1539. PubMed: 15550951.
4. Tupala E, Tiihonen J, (2004) Dopamine and alcoholism: neurobiological basis of ethanol abuse. Prog Neuropsychopharmacol Biol Psychiatry 28: 1221-1247. doi:10.1016/j.pnpbp.2004.06.022. PubMed: 15588749.
5. Morganstern I, Barson JR, Leibowitz SF, (2011) Regulation of drug and palatable food overconsumption by similar peptide systems. Curr Drugs Abuse Rev 4: 163-173. doi:10.2174/1874473711104030163. PubMed: 21999690.
6. Brubaker PL, Anini Y, (2003) Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2. Can J Physiol Pharmacol 81: 1005-1012. doi:10.1139/y03-107. PubMed: 14719035.
7. Novak U, Wilks A, Buell G, McEwen S, (1987) Identical mRNA for preproglucagon in pancreas and gut. Eur J Biochem 164: 553-558. doi:10.1111/j.1432-1033.1987.tb11162.x. PubMed: 3569278.
8. Alvarez E, Roncero I, Chowen JA, Thorens B, Blázquez E, (1996) Expression of the glucagon-like peptide-1 receptor gene in rat brain. J Neurochem 66: 920-927. PubMed: 8769850.
9. Merchenthaler I, Lane M, Shughrue P, (1999) Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system. J Comp Neurol 403: 261-280. doi:10.1002/(SICI)1096-9861(19990111)403:2. PubMed: 9886047.
10. Holst JJ, (2007) The physiology of glucagon-like peptide 1. Physiol Rev 87: 1409-1439. doi:10.1152/physrev.00034.2006. PubMed: 17928588.
11. Baggio LL, Drucker DJ, (2007) Biology of incretins: GLP-1 and GIP. Gastroenterology 132: 2131-2157. doi:10.1053/j.gastro.2007.03.054. PubMed: 17498508.
12. Kreymann B, Williams G, Ghatei MA, Bloom SR, (1987) Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet 2: 1300-1304. PubMed: 2890903.
13. Turton MD, O'Shea D, Gunn I, Beak SA, Edwards CM, et al. (1996) A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379: 69-72. doi:10.1038/379069a0. PubMed: 8538742.
14. Tang-Christensen M, Larsen PJ, Göke R, Fink-Jensen A, Jessop DS, et al. (1996) Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats. Am J Physiol 271: R848-R856. PubMed: 8897973.
15. McMahon LR, Wellman PJ, (1998) PVN infusion of GLP-1-(7-36) amide suppresses feeding but does not induce aversion or alter locomotion in rats. Am J Physiol 274: R23-R29. PubMed: 9458894.
16. Hayes MR, Bradley L, Grill HJ, (2009) Endogenous hindbrain glucagon-like peptide-1 receptor activation contributes to the control of food intake by mediating gastric satiation signaling. Endocrinology 150: 2654-2659. doi:10.1210/en.2008-1479. PubMed: 19264875.
17. Alhadeff AL, Rupprecht LE, Hayes MR, (2012) GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake. Endocrinology 153: 647-658. doi:10.1210/en.2011-1443. PubMed: 22128031.
18. Egecioglu E, Steensland P, Fredriksson I, Feltmann K, Engel JA, et al. (2012) The glucagon-like peptide 1 analogue Exendin-4 attenuates alcohol mediated behaviors in rodents. Psychoneuroendocrinology, 38: 1259-70. doi:10.1016/j.psyneuen.2012.11.009. PubMed: 23219472.
19. Egecioglu E, Engel JA, Jerlhag E, (2013) The glucagon-like Peptide 1 analogue, exendin-4, attenuates the rewarding properties of psychostimulant drugs in mice. PLOS ONE 8: e69010. doi:10.1371/journal.pone.0069010. PubMed: 23874851.
20. Jerlhag E, Engel JA, (2011) Ghrelin receptor antagonism attenuates nicotine-induced locomotor stimulation, accumbal dopamine release and conditioned place preference in mice. Drug Alcohol Depend 117: 126-131. doi:10.1016/j.drugalcdep.2011.01.010. PubMed: 21310553.
21. Thorens B, Porret A, Bühler L, Deng SP, Morel P, et al. (1993) Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor. Diabetes 42: 1678-1682. doi:10.2337/diabetes.42.11.1678. PubMed: 8405712.
22. Göke R, Larsen PJ, Mikkelsen JD, Sheikh SP, (1995) Distribution of GLP-1 binding sites in the rat brain: evidence that exendin-4 is a ligand of brain GLP-1 binding sites. Eur J Neurosci 7: 2294-2300. doi:10.1111/j.1460-9568.1995.tb00650.x. PubMed: 8563978.
23. Jerlhag E, Egecioglu E, Dickson SL, Andersson M, Svensson L, et al. (2006) Ghrelin stimulates locomotor activity and accumbal dopamine-overflow via central cholinergic systems in mice: implications for its involvement in brain reward. Addict Biol 11: 45-54. doi:10.1111/j.1369-1600.2006.00002.x. PubMed: 16759336.
24. Franklin KBJ, Paxinos G, (1996) The Mouse Brain in Stereotaxic Coordinates. New York: Academic Press.
25. Jerlhag E, (2008) Systemic administration of ghrelin induces conditioned place preference and stimulates accumbal dopamine. Addict Biol 13: 358-363. doi:10.1111/j.1369-1600.2008.00125.x. PubMed: 18782383.
26. Sanchis-Segura C, Spanagel R, (2006) Behavioural assessment of drug reinforcement and addictive features in rodents: an overview. Addict Biol 11: 2-38. doi:10.1111/j.1369-1600.2006.00012.x. PubMed: 16759333.
27. Segal DS, Mandell AJ, (1974) Long-term administration of d-amphetamine: progressive augmentation of motor activity and stereotypy. Pharmacol Biochem Behav 2: 249-255. doi:10.1016/0091-3057(74)90060-4. PubMed: 4857295.
28. Clifford PS, Rodriguez J, Schul D, Hughes S, Kniffin T, et al. (2011) Attenuation of cocaine-induced locomotor sensitization in rats sustaining genetic or pharmacologic antagonism of ghrelin receptors. Addict Biol 17(6):: 956-963. PubMed: 21790898.
29. Robinson TE, Berridge KC, (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain. Res Rev 18: 247-291. doi:10.1016/0165-0173(93)90013-P.
30. Rinaman L, (2010) Ascending projections from the caudal visceral nucleus of the solitary tract to brain regions involved in food intake and energy expenditure. Brain Res 1350: 18-34. doi:10.1016/j.brainres.2010.03.059. PubMed: 20353764.
31. Engel JA, Fahlke C, Hulthe P, Hård E, Johannessen K, et al. (1988) Biochemical and behavioral evidence for an interaction between ethanol and calcium channel antagonists. J Neural Transm 74: 181-193. doi:10.1007/BF01244784. PubMed: 3210013.
32. Dickson SL, Shirazi RH, Hansson C, Bergquist F, Nissbrandt H, et al. (2012) The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors. J Neurosci 32: 4812-4820. doi:10.1523/JNEUROSCI.6326-11.2012. PubMed: 22492036.
33. Dossat AM, Lilly N, Kay K, Williams DL, (2011) Glucagon-like peptide 1 receptors in nucleus accumbens affect food intake. J Neurosci 31: 14453-14457. doi:10.1523/JNEUROSCI.3262-11.2011. PubMed: 21994361.
34. Shirazi RH, Dickson SL, Skibicka KP, (2013) Gut peptide GLP-1 and its analogue, Exendin-4, decrease alcohol intake and reward. PLOS ONE 8: e61965. doi:10.1371/journal.pone.0061965. PubMed: 23613987.
35. Sandoval DA, Bagnol D, Woods SC, D'Alessio DA, Seeley RJ, (2008) Arcuate glucagon-like peptide 1 receptors regulate glucose homeostasis but not food intake. Diabetes 57: 2046-2054. doi:10.2337/db07-1824. PubMed: 18487451.
36. Kastin AJ, Akerstrom V, (2003) Entry of exendin-4 into brain is rapid but may be limited at high doses. Int J Obes Relat Metab Disord 27: 313-318. doi:10.1038/sj.ijo.0802206. PubMed: 12629557.
37. Rüttimann EB, Arnold M, Hillebrand JJ, Geary N, Langhans W, (2009) Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms. Endocrinology 150: 1174-1181. PubMed: 18948395.
38. Malendowicz LK, Nussdorfer GG, Nowak KW, Ziolkowska A, Tortorella C, et al. (2003) Exendin-4, a GLP-1 receptor agonist, stimulates pituitary-adrenocortical axis in the rat: Investigations into the mechanism(s) underlying Ex4 effect. Int J Mol Med 12: 237-241. PubMed: 12851724.
39. Sonne DP, Engstrøm T, Treiman M, (2008) Protective effects of GLP-1 analogues exendin-4 and GLP-1(9-36) amide against ischemia-reperfusion injury in rat heart. Regul Pept 146: 243-249. doi:10.1016/j.regpep.2007.10.001. PubMed: 17976835.
40. Barrera JG, D'Alessio DA, Drucker DJ, Woods SC, Seeley RJ, (2009) Differences in the central anorectic effects of glucagon-like peptide-1 and exendin-4 in rats. Diabetes 58: 2820-2827. doi:10.2337/db09-0281. PubMed: 19741167.
41. Erreger K, Davis AR, Poe AM, Greig NH, Stanwood GD, et al. (2012) Exendin-4 decreases amphetamine-induced locomotor activity. Physiol Behav 106: 574-578. doi:10.1016/j.physbeh.2012.03.014. PubMed: 22465309.
42. Graham DL, Erreger K, Galli A, Stanwood GD, (2012) GLP-1 analog attenuates cocaine reward. Mol Psychiatry, 18: 961-2. doi:10.1038/mp.2012.141. PubMed: 23089631.
43. Gutniak M, Orskov C, Holst JJ, Ahrén B, Efendic S, (1992) Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus. N Engl J Med 326: 1316-1322. doi:10.1056/NEJM199205143262003. PubMed: 1348845.
44. Matsuyama T, Komatsu R, Namba M, Watanabe N, Itoh H, et al. (1988) Glucagon-like peptide-1 (7-36 amide): a potent glucagonostatic and insulinotropic hormone. Diabetes Res Clin Pract 5: 281-284. doi:10.1016/S0168-8227(88)80063-9. PubMed: 3069410.
45. Schirra J, Kuwert P, Wank U, Leicht P, Arnold R, et al. (1997) Differential effects of subcutaneous GLP-1 on gastric emptying, antroduodenal motility, and pancreatic function in men. Proc Assoc Am Physicians 109: 84-97. PubMed: 9010920.
46. Holst JJ, Vilsbøll T, Deacon CF, (2009) The incretin system and its role in type 2 diabetes mellitus. Mol Cell Endocrinol 297: 127-136. doi:10.1016/j.mce.2008.08.012. PubMed: 18786605.
47. Kanoski SE, Rupprecht LE, Fortin SM, De Jonghe BC, Hayes MR, (2012) The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide. Neuropharmacology 62: 1916-1927. doi:10.1016/j.neuropharm.2011.12.022. PubMed: 22227019.
48. Cagniard B, Murphy NP, (2012) Affective taste responses in the presence of reward- and aversion-conditioned stimuli and their relationship to psychomotor sensitization and place conditioning. Behav Brain Res 236: 289-294. PubMed: 22940019.
49. Neugebauer NM, Henehan RM, Hales CA, Picciotto MR, (2011) Mice lacking the galanin gene show decreased sensitivity to nicotine conditioned place preference. Pharmacol Biochem Behav 98: 87-93. doi:10.1016/j.pbb.2010.12.015. PubMed: 21172385.
50. von der Goltz C, Koopmann A, Dinter C, Richter A, Rockenbach C, et al. (2010) Orexin and leptin are associated with nicotine craving: a link between smoking, appetite and reward. Psychoneuroendocrinology 35: 570-577. doi:10.1016/j.psyneuen.2009.09.005. PubMed: 19828259.
51. Rasmussen K, Czachura JF, Kallman MJ, Helton DR, (1996) The CCK-B antagonist LY288513 blocks the effects of nicotine withdrawal on auditory startle. Neuroreport 7: 1050-1052. doi:10.1097/00001756-199604100-00019. PubMed: 8804049.